30

Jiangsu Apon Medical Technology Co LtdSHE 300753 Stock Report

Last reporting period 30 Sep, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

0.262

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300753.SZ Stock Analysis

30

Uncovered

Jiangsu Apon Medical Technology Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

8/100

Low score

Market cap $B

0.262

Dividend yield

0.54 %

Shares outstanding

126.05 B

Jiangsu Apon Medical Technology Co., Ltd. engages in the research, development, production, and sale of medical device products for pain management and nasal care. The company is headquartered in Nantong, Jiangsu and currently employs 774 full-time employees. The company went IPO on 2018-12-13. The firm's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The firm operates primarily in domestic and overseas markets.

View Section: Eyestock Rating